Skip to main content
Log in

Synthesis and Analgesic Activity of 3-Arylamino-1,2-Dihydro-3H-1,4-Benzodiazepin-2-Ones

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Abstract

Interaction of 3-chloro-5-aryl-1,2-dihydro-3H-1,4-benzodiazepines with aromatic amines was used to synthesize 3-arylamino-1,2-dihydro-3H-1,4-benzodiazepin-2-ones with analgesic activity in the acetate acid writing test (ED50 0.007 – 3.2 mg).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. J. M. A. Mens, Best Practice Res. Clin. Rheumatol., 19(4), 609 – 621 (2005).

    Article  Google Scholar 

  2. M. Anzini, L. Canullo, C. Braile, et al., J. Med. Chem., 46, 3853 – 3864 (2003).

    Article  CAS  PubMed  Google Scholar 

  3. P. G. Benedetti, M. Sbacchi, G. D. Clarke, and L. Mennuni, J. Med. Chem., 39, 860 – 872 (1996).

    Article  PubMed  Google Scholar 

  4. O. Azzolina, S. Collina, and L. Linati, Chirality, 13, 606 – 612 (2001).

    Article  CAS  PubMed  Google Scholar 

  5. S. A. Andronati, T. A. Kabanova, V. I. Pavlovskii, et al., Zh. Org. Farm. Khim., 7(4), 70 – 76 (2009).

    CAS  Google Scholar 

  6. M. Rezayat, A. Rahnavard, and M.-R. Zarrindast, Pharmacol. Toxicol., 86, 58 – 62 (2000).

    Article  Google Scholar 

  7. B. E. Evans, K. E. Rittle, and M. G. Bock, J. Med. Chem., 31, 2235 – 2246 (1988).

    Article  CAS  PubMed  Google Scholar 

  8. G. A. Showell, S. Bourrain, S. R. Fletcher, et. al., Bioorg. Med. Chem. Lett., 5(24), 3023 – 3026 (1995).

  9. B. Pirotte, P. Tullio, T. Podona, et al., Eur. J. Pharm. Sci., 7, 29 – 40 (1998).

    Article  CAS  PubMed  Google Scholar 

  10. E. Akgüën, M. Körner, F. Gao, et al., J. Med. Chem., 52, 2138 – 2147 (2009).

    Article  Google Scholar 

  11. R. Herranz, Med. Res. Rev., 23(5), 559 – 605 (2003).

    Article  CAS  PubMed  Google Scholar 

  12. M. Offel, P. Lattmann, H. Singh, et al., Arch. Pharm. Chem. Life Sci., 339, 163 – 173 (2006).

    Article  CAS  Google Scholar 

  13. E. Lattmann, P. Lattmann, Y. Boonprakob, et al., Arzneimittel.- Forsch., 58(2), 61 – 71 (2009).

    Google Scholar 

  14. N. Nadzhafi, M. Pirali, R. Daulatobadi, et al., Khim.-Farm. Zh., 39(12), 21 – 23 (2005); Pharm. Chem. J., 39(12), 641 – 643 (2005).

  15. S. Yu. Makan, N. A. Tkachuk, V. M. Korkhov, et al., Khim.- Farm. Zh., 39(6), 19 – 21 (2005); Pharm. Chem. J., 39(6), 300 – 302 (2005).

  16. S. Yu. Makan, N. O. Burenkova, K. A. Kostenko, et al., Visnik Psikhiat. Psikhofarmakoter., 2(12), 118 – 121 (2007).

    Google Scholar 

  17. Yu. Simonov, P. Borosh, V. Kh. Kravtsov, et al., Zh. Org. Farm. Khim., 9(4), 70 – 73 (2011).

    CAS  Google Scholar 

  18. S. A. Andronati, T. L. Karas¸va, A. A. Kazakova, et al., Khim.- Farm. Zh., 45(4), 101 – 102 (2011); Pharm. Chem. J., 45(4), 215 – 216 (2011).

  19. V. I. Pavlovskii, E. A. Semenishina, I. A. Kravchenko, et al., Khim.-Farm. Zh., 46(9), 72 – 77 (2012); Pharm. Chem. J., 46(9), 540 – 545 (2012).

  20. K. S. Andronati, E. A. Kostenko, T. L. Karaseva, and S. A. Andronati, Khim.-Farm. Zh., 36(7), 16 – 18 (2002); Pharm. Chem. J., 36(7), 356 – 359 (2002).

  21. N. A. Burenkova, V. I. Pavlovsky, I. A. Oleinich, et. al., Ukrain. Bioorgan. Acta, 1, 8 – 15 (2009).

  22. G. M. Sheldrick, Acta Cryst., 64(1), 112 (2008).

    Article  CAS  Google Scholar 

  23. S. A. Andronati, K. S. Andronati, D. P. Neshchadin, et al., Dopovidi Nats. Akad. Nauk Ukr., No. 6, 149 – 155 (1999).

  24. W. L Duax, C. M. Weeks, and D. C. Rohrer, Topics Stereochemi., 9, 271 – 283 (1976).

  25. T. A. Hamor, I. L. Martin, Clarendon Press Oxford (1984), pp. 275 – 301.

  26. A. A. Karapetyan, V. G. Andrianov, Yu. T. Struchkov, et al., Bioorgan. Khim., 5(11), 1684 (1979).

    CAS  Google Scholar 

  27. G. Bandoli, D. A. Clemente, and J. C. S. Perkin, 2, 413 – 418 (1976).

  28. Yu. A. Simonov, V. I. Pavlovskii, M. Gdanets, et al., Ukr. Khim. Zh., 75(3 – 4), 56 – 59 (2009).

  29. V. I. Pavlovskii, E. A. Semenishina, S. A. Andronati, et al., Khimiya Geterots. Soedin., 11(509), 1704 – 1724 (2009).

    Google Scholar 

  30. V. Ch. Kravtsov, M. S. Fonari, M. Gdaniec, et al., J. Mol. Struct., 1017, 32 – 37 (2012).

    Article  CAS  Google Scholar 

  31. O. V. Stefanov, Preclinical Studies of Drugs (Methodological Recommendations), Ukrainian Ministry of Health, DFTs, Kiev (2001).

  32. V. B. Prozorovskii, Psikhofarmakol. Biol. Narkol., 7(3 – 4), 2090 – 2120 (2007).

    Google Scholar 

  33. C. G. Heapy, J. S. Shaw, S. C. Farmer, Br. J. Pharmacol., 108(1), 209 – 213 (1993).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. I. Pavlovskii.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 49, No. 9, pp. 22 – 27, September, 2015.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pavlovskii, V.I., Ushakov, I.Y., Kabanova, T.A. et al. Synthesis and Analgesic Activity of 3-Arylamino-1,2-Dihydro-3H-1,4-Benzodiazepin-2-Ones. Pharm Chem J 49, 592–597 (2015). https://doi.org/10.1007/s11094-015-1335-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-015-1335-4

Keywords

Navigation